ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Emenda Therapeutics Ltd

Emenda Therapeutics Ltd is an active company incorporated on 26 November 2018 with the registered office located in Gloucester, Gloucestershire. Emenda Therapeutics Ltd was registered 6 years ago.
Status
Active
Active since incorporation
Company No
11695185
Private limited company
Age
6 years
Incorporated 26 November 2018
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 31 August 2025 (2 months ago)
Next confirmation dated 31 August 2026
Due by 14 September 2026 (10 months remaining)
Last change occurred 2 years 2 months ago
Accounts
Submitted
For period 1 Jun31 May 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 May 2025
Due by 28 February 2026 (3 months remaining)
Address
Goodridge Court
Goodridge Avenue
Gloucester
Gloucestershire
GL2 5EN
United Kingdom
Address changed on 29 Nov 2021 (3 years ago)
Previous address was Shakespeare Martineau Waterfront House Waterfront Plaza 35 Station Street Nottingham Nottinghamshire NG2 3DQ
Telephone
Unreported
Email
Unreported
People
Officers
4
Shareholders
1
Controllers (PSC)
1
Director • Australian • Lives in Australia • Born in Feb 1969
Director • British • Lives in UK • Born in Mar 1967
Director • British • Lives in England • Born in Dec 1984
Emenda Therapeutics Australia Pty Ltd
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Hone Bio Limited
Dr Andrew Michael Chapman is a mutual person.
Active
Medea Therapeutics Limited
Dr Andrew Michael Chapman is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2019–2024)
Period Ended
31 May 2024
For period 31 May31 May 2024
Traded for 12 months
Cash in Bank
£7.93K
Decreased by £1.04K (-12%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£26.73K
Increased by £17.76K (+198%)
Total Liabilities
-£934
Same as previous period
Net Assets
£25.8K
Increased by £17.76K (+221%)
Debt Ratio (%)
3%
Decreased by 6.92% (-66%)
Latest Activity
Confirmation Submitted
2 Months Ago on 8 Sep 2025
Full Accounts Submitted
5 Months Ago on 27 May 2025
Andrew Michael Chapman Resigned
1 Year 2 Months Ago on 12 Sep 2024
Confirmation Submitted
1 Year 2 Months Ago on 9 Sep 2024
Full Accounts Submitted
1 Year 8 Months Ago on 29 Feb 2024
Steven James Harper Resigned
2 Years 2 Months Ago on 2 Sep 2023
Confirmation Submitted
2 Years 2 Months Ago on 31 Aug 2023
Lucy Frances Donaldson (PSC) Resigned
2 Years 8 Months Ago on 1 Mar 2023
Jonathan Morris (PSC) Resigned
2 Years 8 Months Ago on 1 Mar 2023
Keith Joseph Macdonald Resigned
3 Years Ago on 21 Nov 2021
Get Credit Report
Discover Emenda Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 31 August 2025 with no updates
Submitted on 8 Sep 2025
Total exemption full accounts made up to 31 May 2024
Submitted on 27 May 2025
Termination of appointment of Andrew Michael Chapman as a director on 12 September 2024
Submitted on 13 Sep 2024
Confirmation statement made on 31 August 2024 with no updates
Submitted on 9 Sep 2024
Total exemption full accounts made up to 31 May 2023
Submitted on 29 Feb 2024
Termination of appointment of Steven James Harper as a director on 2 September 2023
Submitted on 7 Sep 2023
Termination of appointment of Keith Joseph Macdonald as a director on 21 November 2021
Submitted on 7 Sep 2023
Confirmation statement made on 31 August 2023 with updates
Submitted on 31 Aug 2023
Notification of Emenda Therapeutics Australia Pty Ltd as a person with significant control on 1 March 2023
Submitted on 14 Mar 2023
Cessation of Steven James Harper as a person with significant control on 1 March 2023
Submitted on 14 Mar 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year